1st Quarter - Termination

AFFYMETRIX, INC for AFFYMETRIX INC

Period 1st Quarter 2008 Filed Apr 18, 2008 Signed by Barbara Caulfield, Executive Vice President and General Counsel

Official filing
Firm
AFFYMETRIX, INC
Client
AFFYMETRIX INC
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Mar 31, 2008

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues regarding (1) genetic privacy and nondiscrimination; (2) access to healthcare technology advances; and (3) personalized medicine. Specific legislation: S.306, Genetic Information Nondiscrimination Act (the entire bill) and S.1551, Comprehensive Tuberculosis Elimination Act (the entire bill).

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 306 (110th), S. 1551 (110th)

Science/Technology SCI

Issues regarding intellectual property and furthering research. Specific legislation: HR 977, Genomic Research and Accessibility Act (the entire bill).

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 977 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.